Gemtesa Disease Interactions
There is 1 disease interaction with Gemtesa (vibegron).
Vibegron (applies to Gemtesa) urinary retention
Moderate Potential Hazard, Moderate plausibility.
Vibegron may increase the risk of urinary retention, particularly in patients with bladder outlet obstruction and in those taking muscarinic antagonist medications to treat overactive bladder (OAB). It is recommended to monitor for signs and symptoms of urinary retention and discontinue the use of vibegron if a patient develops urinary retention.
- "Product Information. Gemtesa (vibegron)." Urovant Sciences, Inc (2021):
Gemtesa drug interactions
There are 9 drug interactions with Gemtesa (vibegron).
More about Gemtesa (vibegron)
- Gemtesa consumer information
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (12)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: urinary antispasmodics
- FDA approval history
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.